Apellis Pharmaceuticals Inc P/E Adelante
¿Qué es el P/E Adelante de Apellis Pharmaceuticals Inc?
El P/E Adelante de Apellis Pharmaceuticals Inc es -11.54
¿Cuál es la definición de P/E Adelante?
La relación precio a futuro es la relación entre el precio de las acciones de una empresa y las ganancias por acción estimadas de la compañía para los próximos doce meses.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
P/E Adelante de compañías en Sector Health Care en NASDAQ en comparadas con Apellis Pharmaceuticals Inc
¿Qué hace Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Empresas con p/e adelante similar a Apellis Pharmaceuticals Inc
- Biostage tiene P/E Adelante de -12.00
- Immunovant Inc tiene P/E Adelante de -11.92
- U.S. Xpress Enterprises Inc tiene P/E Adelante de -11.88
- CollPlant Biotechnologies Ltd tiene P/E Adelante de -11.63
- Oncocyte tiene P/E Adelante de -11.63
- Parrot SA tiene P/E Adelante de -11.57
- Apellis Pharmaceuticals Inc tiene P/E Adelante de -11.54
- Biostage tiene P/E Adelante de -11.43
- Soligenix Inc tiene P/E Adelante de -11.34
- Abivax SA tiene P/E Adelante de -11.32
- GrowGeneration Corp tiene P/E Adelante de -11.31
- Obalon Therapeutics Inc tiene P/E Adelante de -11.30
- Cassava Sciences Inc tiene P/E Adelante de -11.29